IGNG - Australian State Expands CBD Program for Epileptic Kids
As the regulations on CBD get less strict, more people have been exposed to the compound, and the numerous medical benefits it has to offer. While scientific research is still scarce, there’s plenty of anecdotal evidence on the effectiveness of cannabidiol, and more people are taking notice of it and of the numerous ailments it is effective against.
In Australia, Victoria has been at the forefront of the medical cannabis campaign. It started in December 2015 with the announcing of the Access to Medical Cannabis Bill. 2017 brought about the Andrews Labor Government’s Compassionate Access Scheme, which gave 29 children who have intractable epilepsy the opportunity to receive CBD based treatments to help manage their symptoms. Minister for Health, Jenny Mikakos, says that the reform was to aid families who were forced to choose between...
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.